Condition: Bronchiectasis · Sponsor: Chiesi Farmaceutici S.p.A.
The aim of this clinical trial is to assess the safety of: * single doses of the study drug CHF6333 in Healthy Volunteers (HVs) and in subjects with Bronchiectasis (BE) - Part I * repeated doses of the study drug CHF6333 in subjects with BE - Part II
This description comes directly from the study's public registry record.
Chiesi Clinical Trial info · +39 0521 2791 · Clinicaltrials_info@chiesi.com
Always discuss trial participation with your own doctor first.
| Royal Papworth Hospital NHS Foundation Trust, Cambridge Centre for Lung Infection | Cambridge, United Kingdom | Recruiting |
| Tayside Medical Science Centre, Ninewells Hospital & Medical School | Dundee, United Kingdom | Recruiting |
| NHS Lothian | Edinburgh, United Kingdom | Recruiting |
| Glasgow Royal Infirmary | Glasgow, United Kingdom | Recruiting |
| The Leeds Teaching Hospitals NHS Trust, Saint James's University Hospital | Leeds, United Kingdom | Withdrawn |
| Royal Bromptom Hospital (NHS Guy's and Thomas') | London, United Kingdom | Recruiting |
| Manchester University NHS Foundation Trust | Manchester, United Kingdom | Recruiting |
| Medicines Evaluation Unit (MEU) | Manchester, United Kingdom | Recruiting |
| University Hospital Southampton NHS Foundation Trust | Southampton, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06166056